グアイフェネシンの世界市場（～2026年）

• 英文タイトル：Global Guaifenesin Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07004 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はグアイフェネシンのグローバル市場について調査・分析したレポートです。種類別（98％-99％、99％以上）市場規模、用途別（医薬品、パーソナルケア製品、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グアイフェネシンの競争状況、市場シェア ・世界のグアイフェネシン市場：種類別市場規模 2015年-2020年（98％-99％、99％以上） ・世界のグアイフェネシン市場：種類別市場規模予測 2021年-2026年（98％-99％、99％以上） ・世界のグアイフェネシン市場：用途別市場規模 2015年-2020年（医薬品、パーソナルケア製品、その他） ・世界のグアイフェネシン市場：用途別市場規模予測 2021年-2026年（医薬品、パーソナルケア製品、その他） ・北米のグアイフェネシン市場分析：米国、カナダ ・ヨーロッパのグアイフェネシン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグアイフェネシン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグアイフェネシン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグアイフェネシン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Granules、Synthokem Labs、Haizhou Pharma、Yuan Cheng Group、Stellar Chemical、Biesterfeld、Seven Star Pharma、Camlin Fine Science、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Delta Synthetic、Smart Pharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Guaifenesin Market
The global Guaifenesin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Guaifenesin Scope and Market Size
Guaifenesin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Guaifenesin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Guaifenesin market is segmented into
98%-99%
Above 99%

Segment by Application, the Guaifenesin market is segmented into
Pharmaceuticals
Personal Care Products
Others

Regional and Country-level Analysis
The Guaifenesin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Guaifenesin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Guaifenesin Market Share Analysis
Guaifenesin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Guaifenesin business, the date to enter into the Guaifenesin market, Guaifenesin product introduction, recent developments, etc.

The major vendors covered:
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm

レポート目次

---

1 Study Coverage
1.1 Guaifenesin Product Introduction
1.2 Market Segments
1.3 Key Guaifenesin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Guaifenesin Market Size Growth Rate by Type
1.4.2 98%-99%
1.4.3 Above 99%
1.5 Market by Application
1.5.1 Global Guaifenesin Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Personal Care Products
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Guaifenesin Market Size, Estimates and Forecasts
2.1.1 Global Guaifenesin Revenue 2015-2026
2.1.2 Global Guaifenesin Sales 2015-2026
2.2 Global Guaifenesin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Guaifenesin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Guaifenesin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Guaifenesin Competitor Landscape by Players
3.1 Guaifenesin Sales by Manufacturers
3.1.1 Guaifenesin Sales by Manufacturers (2015-2020)
3.1.2 Guaifenesin Sales Market Share by Manufacturers (2015-2020)
3.2 Guaifenesin Revenue by Manufacturers
3.2.1 Guaifenesin Revenue by Manufacturers (2015-2020)
3.2.2 Guaifenesin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Guaifenesin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Guaifenesin Revenue in 2019
3.2.5 Global Guaifenesin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Guaifenesin Price by Manufacturers
3.4 Guaifenesin Manufacturing Base Distribution, Product Types
3.4.1 Guaifenesin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Guaifenesin Product Type
3.4.3 Date of International Manufacturers Enter into Guaifenesin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Guaifenesin Market Size by Type (2015-2020)
4.1.1 Global Guaifenesin Sales by Type (2015-2020)
4.1.2 Global Guaifenesin Revenue by Type (2015-2020)
4.1.3 Guaifenesin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Guaifenesin Market Size Forecast by Type (2021-2026)
4.2.1 Global Guaifenesin Sales Forecast by Type (2021-2026)
4.2.2 Global Guaifenesin Revenue Forecast by Type (2021-2026)
4.2.3 Guaifenesin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Guaifenesin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Guaifenesin Market Size by Application (2015-2020)
5.1.1 Global Guaifenesin Sales by Application (2015-2020)
5.1.2 Global Guaifenesin Revenue by Application (2015-2020)
5.1.3 Guaifenesin Price by Application (2015-2020)
5.2 Guaifenesin Market Size Forecast by Application (2021-2026)
5.2.1 Global Guaifenesin Sales Forecast by Application (2021-2026)
5.2.2 Global Guaifenesin Revenue Forecast by Application (2021-2026)
5.2.3 Global Guaifenesin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Guaifenesin by Country
6.1.1 North America Guaifenesin Sales by Country
6.1.2 North America Guaifenesin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Guaifenesin Market Facts & Figures by Type
6.3 North America Guaifenesin Market Facts & Figures by Application

7 Europe
7.1 Europe Guaifenesin by Country
7.1.1 Europe Guaifenesin Sales by Country
7.1.2 Europe Guaifenesin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Guaifenesin Market Facts & Figures by Type
7.3 Europe Guaifenesin Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Guaifenesin by Region
8.1.1 Asia Pacific Guaifenesin Sales by Region
8.1.2 Asia Pacific Guaifenesin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Guaifenesin Market Facts & Figures by Type
8.3 Asia Pacific Guaifenesin Market Facts & Figures by Application

9 Latin America
9.1 Latin America Guaifenesin by Country
9.1.1 Latin America Guaifenesin Sales by Country
9.1.2 Latin America Guaifenesin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Guaifenesin Market Facts & Figures by Type
9.3 Central & South America Guaifenesin Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Guaifenesin by Country
10.1.1 Middle East and Africa Guaifenesin Sales by Country
10.1.2 Middle East and Africa Guaifenesin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Guaifenesin Market Facts & Figures by Type
10.3 Middle East and Africa Guaifenesin Market Facts & Figures by Application

11 Company Profiles
11.1 Granules
11.1.1 Granules Corporation Information
11.1.2 Granules Description and Business Overview
11.1.3 Granules Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Granules Guaifenesin Products Offered
11.1.5 Granules Related Developments
11.2 Synthokem Labs
11.2.1 Synthokem Labs Corporation Information
11.2.2 Synthokem Labs Description and Business Overview
11.2.3 Synthokem Labs Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Synthokem Labs Guaifenesin Products Offered
11.2.5 Synthokem Labs Related Developments
11.3 Haizhou Pharma
11.3.1 Haizhou Pharma Corporation Information
11.3.2 Haizhou Pharma Description and Business Overview
11.3.3 Haizhou Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Haizhou Pharma Guaifenesin Products Offered
11.3.5 Haizhou Pharma Related Developments
11.4 Yuan Cheng Group
11.4.1 Yuan Cheng Group Corporation Information
11.4.2 Yuan Cheng Group Description and Business Overview
11.4.3 Yuan Cheng Group Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Yuan Cheng Group Guaifenesin Products Offered
11.4.5 Yuan Cheng Group Related Developments
11.5 Stellar Chemical
11.5.1 Stellar Chemical Corporation Information
11.5.2 Stellar Chemical Description and Business Overview
11.5.3 Stellar Chemical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Stellar Chemical Guaifenesin Products Offered
11.5.5 Stellar Chemical Related Developments
11.6 Biesterfeld
11.6.1 Biesterfeld Corporation Information
11.6.2 Biesterfeld Description and Business Overview
11.6.3 Biesterfeld Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biesterfeld Guaifenesin Products Offered
11.6.5 Biesterfeld Related Developments
11.7 Seven Star Pharma
11.7.1 Seven Star Pharma Corporation Information
11.7.2 Seven Star Pharma Description and Business Overview
11.7.3 Seven Star Pharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Seven Star Pharma Guaifenesin Products Offered
11.7.5 Seven Star Pharma Related Developments
11.8 Camlin Fine Science
11.8.1 Camlin Fine Science Corporation Information
11.8.2 Camlin Fine Science Description and Business Overview
11.8.3 Camlin Fine Science Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Camlin Fine Science Guaifenesin Products Offered
11.8.5 Camlin Fine Science Related Developments
11.9 Gennex Lab
11.9.1 Gennex Lab Corporation Information
11.9.2 Gennex Lab Description and Business Overview
11.9.3 Gennex Lab Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gennex Lab Guaifenesin Products Offered
11.9.5 Gennex Lab Related Developments
11.10 Iwaki Seiyaku
11.10.1 Iwaki Seiyaku Corporation Information
11.10.2 Iwaki Seiyaku Description and Business Overview
11.10.3 Iwaki Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Iwaki Seiyaku Guaifenesin Products Offered
11.10.5 Iwaki Seiyaku Related Developments
11.1 Granules
11.1.1 Granules Corporation Information
11.1.2 Granules Description and Business Overview
11.1.3 Granules Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Granules Guaifenesin Products Offered
11.1.5 Granules Related Developments
11.12 Delta Synthetic
11.12.1 Delta Synthetic Corporation Information
11.12.2 Delta Synthetic Description and Business Overview
11.12.3 Delta Synthetic Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Delta Synthetic Products Offered
11.12.5 Delta Synthetic Related Developments
11.13 Smart Pharm
11.13.1 Smart Pharm Corporation Information
11.13.2 Smart Pharm Description and Business Overview
11.13.3 Smart Pharm Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Smart Pharm Products Offered
11.13.5 Smart Pharm Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Guaifenesin Market Estimates and Projections by Region
12.1.1 Global Guaifenesin Sales Forecast by Regions 2021-2026
12.1.2 Global Guaifenesin Revenue Forecast by Regions 2021-2026
12.2 North America Guaifenesin Market Size Forecast (2021-2026)
12.2.1 North America: Guaifenesin Sales Forecast (2021-2026)
12.2.2 North America: Guaifenesin Revenue Forecast (2021-2026)
12.2.3 North America: Guaifenesin Market Size Forecast by Country (2021-2026)
12.3 Europe Guaifenesin Market Size Forecast (2021-2026)
12.3.1 Europe: Guaifenesin Sales Forecast (2021-2026)
12.3.2 Europe: Guaifenesin Revenue Forecast (2021-2026)
12.3.3 Europe: Guaifenesin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Guaifenesin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Guaifenesin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Guaifenesin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Guaifenesin Market Size Forecast by Region (2021-2026)
12.5 Latin America Guaifenesin Market Size Forecast (2021-2026)
12.5.1 Latin America: Guaifenesin Sales Forecast (2021-2026)
12.5.2 Latin America: Guaifenesin Revenue Forecast (2021-2026)
12.5.3 Latin America: Guaifenesin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Guaifenesin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Guaifenesin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Guaifenesin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Guaifenesin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Guaifenesin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Guaifenesin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Guaifenesin Market Segments
Table 2. Ranking of Global Top Guaifenesin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Guaifenesin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of 98%-99%
Table 5. Major Manufacturers of Above 99%
Table 6. Global Guaifenesin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Guaifenesin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Guaifenesin Sales by Regions 2015-2020 (K MT)
Table 9. Global Guaifenesin Sales Market Share by Regions (2015-2020)
Table 10. Global Guaifenesin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Guaifenesin Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Guaifenesin Sales Share by Manufacturers (2015-2020)
Table 13. Global Guaifenesin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Guaifenesin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin as of 2019)
Table 15. Guaifenesin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Guaifenesin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Guaifenesin Price (2015-2020) (USD/MT)
Table 18. Guaifenesin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Guaifenesin Product Type
Table 20. Date of International Manufacturers Enter into Guaifenesin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Guaifenesin Sales by Type (2015-2020) (K MT)
Table 23. Global Guaifenesin Sales Share by Type (2015-2020)
Table 24. Global Guaifenesin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Guaifenesin Revenue Share by Type (2015-2020)
Table 26. Guaifenesin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Guaifenesin Sales by Application (2015-2020) (K MT)
Table 28. Global Guaifenesin Sales Share by Application (2015-2020)
Table 29. North America Guaifenesin Sales by Country (2015-2020) (K MT)
Table 30. North America Guaifenesin Sales Market Share by Country (2015-2020)
Table 31. North America Guaifenesin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Guaifenesin Revenue Market Share by Country (2015-2020)
Table 33. North America Guaifenesin Sales by Type (2015-2020) (K MT)
Table 34. North America Guaifenesin Sales Market Share by Type (2015-2020)
Table 35. North America Guaifenesin Sales by Application (2015-2020) (K MT)
Table 36. North America Guaifenesin Sales Market Share by Application (2015-2020)
Table 37. Europe Guaifenesin Sales by Country (2015-2020) (K MT)
Table 38. Europe Guaifenesin Sales Market Share by Country (2015-2020)
Table 39. Europe Guaifenesin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Guaifenesin Revenue Market Share by Country (2015-2020)
Table 41. Europe Guaifenesin Sales by Type (2015-2020) (K MT)
Table 42. Europe Guaifenesin Sales Market Share by Type (2015-2020)
Table 43. Europe Guaifenesin Sales by Application (2015-2020) (K MT)
Table 44. Europe Guaifenesin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Guaifenesin Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Guaifenesin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Guaifenesin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Guaifenesin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Guaifenesin Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Guaifenesin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Guaifenesin Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Guaifenesin Sales Market Share by Application (2015-2020)
Table 53. Latin America Guaifenesin Sales by Country (2015-2020) (K MT)
Table 54. Latin America Guaifenesin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Guaifenesin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Guaifenesin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Guaifenesin Sales by Type (2015-2020) (K MT)
Table 58. Latin America Guaifenesin Sales Market Share by Type (2015-2020)
Table 59. Latin America Guaifenesin Sales by Application (2015-2020) (K MT)
Table 60. Latin America Guaifenesin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Guaifenesin Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Guaifenesin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Guaifenesin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Guaifenesin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Guaifenesin Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Guaifenesin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Guaifenesin Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Guaifenesin Sales Market Share by Application (2015-2020)
Table 69. Granules Corporation Information
Table 70. Granules Description and Major Businesses
Table 71. Granules Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Granules Product
Table 73. Granules Recent Development
Table 74. Synthokem Labs Corporation Information
Table 75. Synthokem Labs Description and Major Businesses
Table 76. Synthokem Labs Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Synthokem Labs Product
Table 78. Synthokem Labs Recent Development
Table 79. Haizhou Pharma Corporation Information
Table 80. Haizhou Pharma Description and Major Businesses
Table 81. Haizhou Pharma Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Haizhou Pharma Product
Table 83. Haizhou Pharma Recent Development
Table 84. Yuan Cheng Group Corporation Information
Table 85. Yuan Cheng Group Description and Major Businesses
Table 86. Yuan Cheng Group Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Yuan Cheng Group Product
Table 88. Yuan Cheng Group Recent Development
Table 89. Stellar Chemical Corporation Information
Table 90. Stellar Chemical Description and Major Businesses
Table 91. Stellar Chemical Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Stellar Chemical Product
Table 93. Stellar Chemical Recent Development
Table 94. Biesterfeld Corporation Information
Table 95. Biesterfeld Description and Major Businesses
Table 96. Biesterfeld Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Biesterfeld Product
Table 98. Biesterfeld Recent Development
Table 99. Seven Star Pharma Corporation Information
Table 100. Seven Star Pharma Description and Major Businesses
Table 101. Seven Star Pharma Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Seven Star Pharma Product
Table 103. Seven Star Pharma Recent Development
Table 104. Camlin Fine Science Corporation Information
Table 105. Camlin Fine Science Description and Major Businesses
Table 106. Camlin Fine Science Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Camlin Fine Science Product
Table 108. Camlin Fine Science Recent Development
Table 109. Gennex Lab Corporation Information
Table 110. Gennex Lab Description and Major Businesses
Table 111. Gennex Lab Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Gennex Lab Product
Table 113. Gennex Lab Recent Development
Table 114. Iwaki Seiyaku Corporation Information
Table 115. Iwaki Seiyaku Description and Major Businesses
Table 116. Iwaki Seiyaku Guaifenesin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Iwaki Seiyaku Product
Table 118. Iwaki Seiyaku Recent Development
Table 119. Pan Drugs Corporation Information
Table 120. Pan Drugs Description and Major Businesses
Table 121. Pan Drugs Guaifenesin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Pan Drugs Product
Table 123. Pan Drugs Recent Development
Table 124. Delta Synthetic Corporation Information
Table 125. Delta Synthetic Description and Major Businesses
Table 126. Delta Synthetic Guaifenesin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Delta Synthetic Product
Table 128. Delta Synthetic Recent Development
Table 129. Smart Pharm Corporation Information
Table 130. Smart Pharm Description and Major Businesses
Table 131. Smart Pharm Guaifenesin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Smart Pharm Product
Table 133. Smart Pharm Recent Development
Table 134. Global Guaifenesin Sales Forecast by Regions (2021-2026) (K MT)
Table 135. Global Guaifenesin Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Guaifenesin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Guaifenesin Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Guaifenesin Sales Forecast by Country (2021-2026) (K MT)
Table 139. North America: Guaifenesin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Guaifenesin Sales Forecast by Country (2021-2026) (K MT)
Table 141. Europe: Guaifenesin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Guaifenesin Sales Forecast by Region (2021-2026) (K MT)
Table 143. Asia Pacific: Guaifenesin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Guaifenesin Sales Forecast by Country (2021-2026) (K MT)
Table 145. Latin America: Guaifenesin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Guaifenesin Sales Forecast by Country (2021-2026) (K MT)
Table 147. Middle East and Africa: Guaifenesin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Guaifenesin Players
Table 152. Guaifenesin Customers List
Table 153. Guaifenesin Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Guaifenesin Product Picture
Figure 2. Global Guaifenesin Sales Market Share by Type in 2020 & 2026
Figure 3. 98%-99% Product Picture
Figure 4. Above 99% Product Picture
Figure 5. Global Guaifenesin Sales Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals
Figure 7. Personal Care Products
Figure 8. Others
Figure 9. Guaifenesin Report Years Considered
Figure 10. Global Guaifenesin Market Size 2015-2026 (US$ Million)
Figure 11. Global Guaifenesin Sales 2015-2026 (K MT)
Figure 12. Global Guaifenesin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Guaifenesin Sales Market Share by Region (2015-2020)
Figure 14. Global Guaifenesin Sales Market Share by Region in 2019
Figure 15. Global Guaifenesin Revenue Market Share by Region (2015-2020)
Figure 16. Global Guaifenesin Revenue Market Share by Region in 2019
Figure 17. Global Guaifenesin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Guaifenesin Revenue in 2019
Figure 19. Guaifenesin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Guaifenesin Sales Market Share by Type (2015-2020)
Figure 21. Global Guaifenesin Sales Market Share by Type in 2019
Figure 22. Global Guaifenesin Revenue Market Share by Type (2015-2020)
Figure 23. Global Guaifenesin Revenue Market Share by Type in 2019
Figure 24. Global Guaifenesin Market Share by Price Range (2015-2020)
Figure 25. Global Guaifenesin Sales Market Share by Application (2015-2020)
Figure 26. Global Guaifenesin Sales Market Share by Application in 2019
Figure 27. Global Guaifenesin Revenue Market Share by Application (2015-2020)
Figure 28. Global Guaifenesin Revenue Market Share by Application in 2019
Figure 29. North America Guaifenesin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Guaifenesin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Guaifenesin Sales Market Share by Country in 2019
Figure 32. North America Guaifenesin Revenue Market Share by Country in 2019
Figure 33. U.S. Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Guaifenesin Market Share by Type in 2019
Figure 38. North America Guaifenesin Market Share by Application in 2019
Figure 39. Europe Guaifenesin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Guaifenesin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Guaifenesin Sales Market Share by Country in 2019
Figure 42. Europe Guaifenesin Revenue Market Share by Country in 2019
Figure 43. Germany Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Guaifenesin Market Share by Type in 2019
Figure 54. Europe Guaifenesin Market Share by Application in 2019
Figure 55. Asia Pacific Guaifenesin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Guaifenesin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Guaifenesin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Guaifenesin Revenue Market Share by Region in 2019
Figure 59. China Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Guaifenesin Market Share by Type in 2019
Figure 82. Asia Pacific Guaifenesin Market Share by Application in 2019
Figure 83. Latin America Guaifenesin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Guaifenesin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Guaifenesin Sales Market Share by Country in 2019
Figure 86. Latin America Guaifenesin Revenue Market Share by Country in 2019
Figure 87. Mexico Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Guaifenesin Market Share by Type in 2019
Figure 94. Latin America Guaifenesin Market Share by Application in 2019
Figure 95. Middle East and Africa Guaifenesin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Guaifenesin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Guaifenesin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Guaifenesin Revenue Market Share by Country in 2019
Figure 99. Turkey Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Guaifenesin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Guaifenesin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Guaifenesin Market Share by Type in 2019
Figure 106. Middle East and Africa Guaifenesin Market Share by Application in 2019
Figure 107. North America Guaifenesin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Guaifenesin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Guaifenesin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Guaifenesin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Guaifenesin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Guaifenesin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Guaifenesin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Guaifenesin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Guaifenesin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Guaifenesin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed

---